LCAT and Fish-eye disease: Treatment options for FED have been quite limited, but advances in gene therapy (directed to the liver to introduce a functional copy of the LCAT gene) and therapeutic enzyme replacement (potential replacement of the missing LCAT enzyme) represent promising avenues.